Care management and 90-day post discharge mortality in patients hospitalized for myocardial infarction and COVID-19: A French nationwide observational study.

Autor: Grave C; Santé Publique France (French Public Health Agency), 94415 Saint-Maurice, France. Electronic address: clemence.grave@santepubliquefrance.fr., Gabet A; Santé Publique France (French Public Health Agency), 94415 Saint-Maurice, France., Empana JP; Inserm, UMR-S970, department of epidemiology, Paris Cardiovascular Research Centre, université Paris Descartes, 75015 Paris, France., Puymirat E; Department of cardiology, hôpital Européen Georges-Pompidou, université Paris-Descartes, AP-HP, 75015 Paris, France., Tuppin P; Caisse Nationale de l'Assurance Maladie (French National Health Insurance), 75020 Paris, France., Danchin N; Department of cardiology, hôpital Européen Georges-Pompidou, université Paris-Descartes, AP-HP, 75015 Paris, France., Olié V; Santé Publique France (French Public Health Agency), 94415 Saint-Maurice, France.
Jazyk: angličtina
Zdroj: Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2022 Jan; Vol. 115 (1), pp. 37-47. Date of Electronic Publication: 2021 Dec 13.
DOI: 10.1016/j.acvd.2021.11.002
Abstrakt: Background: Concomitant or cured coronavirus disease 2019 (COVID-19) in patients with myocardial infarction (MI) may lead to difficulties in acute care management and impair prognosis.
Aims: To describe and compare the characteristics, care management and 90-day post discharge outcomes of patients hospitalized for MI who did not have COVID-19 with those of patients with concomitant or previous hospital-diagnosed COVID-19.
Methods: This population-based French study included all patients hospitalized for MI in France (30 December 2019 to 04 October 2020) from the French National Health Data System. Outcomes were described for each COVID-19 group and compared using adjusted logistic regression analysis.
Results: Among 55,524 patients hospitalized for MI, 135 had previous hospital-diagnosed COVID-19 and 329 had concomitant COVID-19. Patients with previous hospital-diagnosed COVID-19 had more personal history of cardiovascular diseases than those without concomitant/previous confirmed COVID-19. In-hospital and 90-day post discharge mortality rates of patients with previous COVID-19 were 8.1% and 4.0%, respectively, compared with 3.5% and 3.0% in patients without concomitant/previous confirmed COVID-19 (odds ratio [OR] adj in-hospital 1.83, 95% confidence interval [CI] 0.97-3.46; OR adj post discharge 0.77, 95% CI 0.28-2.13). Patients with concomitant COVID-19 had more personal history of cardiovascular diseases, but also a poorer prognosis than their no concomitant/no previous confirmed COVID-19 counterparts; they presented excess cardiac complications during hospitalization (OR adj 1.62, 95% CI 1.29-2.04), in-hospital mortality (OR adj 3.31, 95% CI 2.32-4.72) and 90-day post discharge mortality (OR adj 2.09, 95% CI 1.24-3.51).
Conclusions: In-hospital and 90-day post discharge mortality of patients hospitalized for MI who had previous hospital-diagnosed COVID-19 did not seem to differ from those hospitalized for MI alone. Conversely, concomitant COVID-19 and MI carried a poorer prognosis extending beyond the hospital stay. Special attention should be given to patients with simultaneous COVID-19 and MI, in terms of acute care and secondary prevention.
(Copyright © 2021 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: